HU308, A Selective Cannabinoid Type-2 Receptor Agonist, Mitigates SARS-CoV-2 Spike Protein–Induced Acute Lung Injury in Mice
CB2R activation ameliorates S1SP-induced lung inflammation and injury, suggesting its therapeutic potential against COVID-19-related ALI.
Authors
- Nagaraja N. Nagre (ORCID: https://orcid.org/0000-0003-0184-8196)
- J. Lockett
- G. Nicholson
- R. J. Washington
- Nicholas Richards
Institutions
- Eastern Virginia Medical School (US)
- Old Dominion University (US)
Publication Details
- Journal
- Lung
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1007/s00408-026-00870-6
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Old Dominion University
- Eastern Virginia Medical School